Technology Transfer Officer Sample Clauses
Technology Transfer Officer. Surname Weetall Forenames ▇▇▇▇▇ L Title (Dr etc.) Director Pharmacology, (Ph.D.) Q2 Title of project: (no more than 220 characters) Discovery and development of a novel glioblastoma treatment that selectively reduces Bmi-1 expression in tumour stem cells PTC Therapeutics, Inc. ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇ Q4 Type of Translation Award requested: SEEDING DRUG DISCOVERY Q5 Period for which support is sought: (state in months) 30 Q6 Proposed start date: (dd/mm/yy) 01/07/2010 Name ▇▇▇▇▇▇ ▇. ▇▇▇▇▇, Ph.D. Telephone numbers: Contact address PTC Therapeutics, Inc. Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Mobile [**] ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Fax. [**] e-mail [**]
Technology Transfer Officer. Surname Forenames Title (Dr etc.) Q2 Title of project: (no more than 220 characters) A First-in-Human Phase I Clinical Trial for the Novel Clostridium difficile Antibiotic SMT19969 Q3 Company name and address or department name and address at administering institution: Summit PLC, 91 ▇▇▇▇▇▇ ▇▇▇▇, Abingdon, Oxfordshire, OX14 4RY Q4 Type of Translation Award requested: (Strategic Awards by prior agreement only) TRANSLATION AWARD Q5 Period for which support is sought: (state in months) 12 Q6 Proposed start date: (dd/mm/yy) 06/08/2012 FRONT PAGE 71 Name Ri▇▇▇▇▇ ▇▇▇▇▇▇▇ Telephone numbers: Contact address 91 ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ Oxfordshire OX14 4RY Day [**] Mobile [**] Fax. [**]
Technology Transfer Officer. Surname ▇▇▇▇▇▇▇ Forenames Don Title (Dr etc.) Mr Q2 Title of project: (no more than 220 characters) Lead Optimisation and development of novel bacterial DNA synthesis inhibitors for the treatment of nosocomial infections caused by multi-drug resistant Gram-negative bacteria PTC Therapeutics, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Q4 Type of Translation Award requested: SEEDING DRUG DISCOVERY Q5 Period for which support is sought:(state in months) 30 months Q6 Proposed start date: (dd/mm/yy) 01/01/12 Name ▇▇▇▇ ▇▇▇▇▇▇ V.N. ▇▇▇▇▇▇▇ Telephone numbers: Contact address PTC Therapeutics, Inc Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile [**] USA Fax. [**] e-mail [**] Name ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Telephone numbers: Contact address PTC Therapeutics, Inc Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile [**] USA Fax, [**] e-mail [**] Name Telephone numbers: Contact address Day Mobile Fax. e-mail Name ▇▇▇ ▇▇▇▇▇▇▇ Telephone numbers: Contact address PTC Therapeutics, Inc Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile USA Fax. [**] e-mail [**] Name ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ Telephone numbers: Contact address PTC Therapeutics, Inc Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile [**] USA Fax. [**] e-mail [**] Contact details Company number: 1-908-222-7000 Date and place of incorporation: March 31, 1998, Delaware Shared capital: Authorised: Preferred Stock – 156,995,095, Common Stock – 26,000,000 Issued: Preferred – 154,728,267, Common – 130,586 Details of Project Registered holders (name, number and type): Credit Suisse First Boston Equity Partners,
Technology Transfer Officer. Surname ▇▇▇▇▇▇▇ Forenames Don Title (Dr etc.) Mr Q2 Title of project: (no more than 220 characters) Lead Optimisation and development of novel bacterial DNA synthesis inhibitors for the treatment of nosocomial infections caused by multi-drug resistant Gram-negative bacteria PTC Therapeutics, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Q4 Type of Translation Award requested: SEEDING DRUG DISCOVERY Q5 Period for which support is sought:(state in months) 30 months Q6 Proposed start date: (dd/mm/yy) 01/01/12 Name ▇▇▇▇ ▇▇▇▇▇▇ V.N. ▇▇▇▇▇▇▇ Telephone numbers: Contact address PTC Therapeutics, Inc Day [**] ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile [**] USA Fax. [**] e-mail [**]